These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28439006)

  • 1. Murine model indicates 22q11.2 signaling adaptor
    Haller M; Mo Q; Imamoto A; Lamb DJ
    Proc Natl Acad Sci U S A; 2017 May; 114(19):4981-4986. PubMed ID: 28439006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Drivers of Kidney Defects in the DiGeorge Syndrome.
    Lopez-Rivera E; Liu YP; Verbitsky M; Anderson BR; Capone VP; Otto EA; Yan Z; Mitrotti A; Martino J; Steers NJ; Fasel DA; Vukojevic K; Deng R; Racedo SE; Liu Q; Werth M; Westland R; Vivante A; Makar GS; Bodria M; Sampson MG; Gillies CE; Vega-Warner V; Maiorana M; Petrey DS; Honig B; Lozanovski VJ; Salomon R; Heidet L; Carpentier W; Gaillard D; Carrea A; Gesualdo L; Cusi D; Izzi C; Scolari F; van Wijk JA; Arapovic A; Saraga-Babic M; Saraga M; Kunac N; Samii A; McDonald-McGinn DM; Crowley TB; Zackai EH; Drozdz D; Miklaszewska M; Tkaczyk M; Sikora P; Szczepanska M; Mizerska-Wasiak M; Krzemien G; Szmigielska A; Zaniew M; Darlow JM; Puri P; Barton D; Casolari E; Furth SL; Warady BA; Gucev Z; Hakonarson H; Flogelova H; Tasic V; Latos-Bielenska A; Materna-Kiryluk A; Allegri L; Wong CS; Drummond IA; D'Agati V; Imamoto A; Barasch JM; Hildebrandt F; Kiryluk K; Lifton RP; Morrow BE; Jeanpierre C; Papaioannou VE; Ghiggeri GM; Gharavi AG; Katsanis N; Sanna-Cherchi S
    N Engl J Med; 2017 Feb; 376(8):742-754. PubMed ID: 28121514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome.
    Guris DL; Duester G; Papaioannou VE; Imamoto A
    Dev Cell; 2006 Jan; 10(1):81-92. PubMed ID: 16399080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome.
    Guris DL; Fantes J; Tara D; Druker BJ; Imamoto A
    Nat Genet; 2001 Mar; 27(3):293-8. PubMed ID: 11242111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse and human CRKL is dosage sensitive for cardiac outflow tract formation.
    Racedo SE; McDonald-McGinn DM; Chung JH; Goldmuntz E; Zackai E; Emanuel BS; Zhou B; Funke B; Morrow BE
    Am J Hum Genet; 2015 Feb; 96(2):235-44. PubMed ID: 25658046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes.
    Moon AM; Guris DL; Seo JH; Li L; Hammond J; Talbot A; Imamoto A
    Dev Cell; 2006 Jan; 10(1):71-80. PubMed ID: 16399079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 16p11.2 transcription factor
    Haller M; Au J; O'Neill M; Lamb DJ
    Proc Natl Acad Sci U S A; 2018 Feb; 115(8):E1849-E1858. PubMed ID: 29432158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migration of sympathetic preganglionic neurons in the spinal cord is regulated by Reelin-dependent Dab1 tyrosine phosphorylation and CrkL.
    Yip YP; Kronstadt-O'Brien P; Capriotti C; Cooper JA; Yip JW
    J Comp Neurol; 2007 Jun; 502(4):635-43. PubMed ID: 17394141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phenotypic and genotypic analysis of a fetus carrying an intermediate 22q11.2 deletion encompassing the CRKL gene].
    Lin S; Zheng X; Gu H; Li M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Jun; 34(3):393-397. PubMed ID: 28604963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of the
    Imamoto A; Ki S; Li L; Iwamoto K; Maruthamuthu V; Devany J; Lu O; Kanazawa T; Zhang S; Yamada T; Hirayama A; Fukuda S; Suzuki Y; Okada M
    Life Sci Alliance; 2020 Feb; 3(2):. PubMed ID: 32041892
    [No Abstract]   [Full Text] [Related]  

  • 11. Inactivation of TGFbeta signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome.
    Wurdak H; Ittner LM; Lang KS; Leveen P; Suter U; Fischer JA; Karlsson S; Born W; Sommer L
    Genes Dev; 2005 Mar; 19(5):530-5. PubMed ID: 15741317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genitourinary defects associated with genomic deletions in 2p15 encompassing OTX1.
    Jorgez CJ; Rosenfeld JA; Wilken NR; Vangapandu HV; Sahin A; Pham D; Carvalho CM; Bandholz A; Miller A; Weaver DD; Burton B; Babu D; Bamforth JS; Wilks T; Flynn DP; Roeder E; Patel A; Cheung SW; Lupski JR; Lamb DJ
    PLoS One; 2014; 9(9):e107028. PubMed ID: 25203062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent amplification in the 22q11 region in laryngeal squamous cell carcinoma results in overexpression of the CRKL but not the MAPK1 oncogene.
    Kostrzewska-Poczekaj M; Giefing M; Jarmuz M; Brauze D; Pelinska K; Grenman R; Bartochowska A; Szyfter W; Szyfter K
    Cancer Biomark; 2010-2011; 8(1):11-9. PubMed ID: 21896986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of CRKL expression in patients with partial DiGeorge syndrome is associated with impairment of T-cell functions.
    Giacomelli M; Kumar R; Soresina A; Tamassia N; Lorenzini T; Moratto D; Gasperini S; Cassatella M; Plebani A; Lougaris V; Badolato R
    J Allergy Clin Immunol; 2016 Jul; 138(1):229-240.e3. PubMed ID: 26875746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital heart defects in a novel recurrent 22q11.2 deletion harboring the genes CRKL and MAPK1.
    Breckpot J; Thienpont B; Bauters M; Tranchevent LC; Gewillig M; Allegaert K; Vermeesch JR; Moreau Y; Devriendt K
    Am J Med Genet A; 2012 Mar; 158A(3):574-80. PubMed ID: 22318985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygosity of murine Crkl does not recapitulate behavioral dimensions of human 22q11.2 hemizygosity.
    Yamauchi T; Kang G; Hiroi N
    Genes Brain Behav; 2021 Jun; 20(5):e12719. PubMed ID: 33269541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene dosage changes in KCTD13 result in penile and testicular anomalies via diminished androgen receptor function.
    Seth A; Rivera A; Chahdi A; Choi IS; Medina-Martinez O; Lewis S; O'Neill M; Ridgeway A; Moore J; Jorgez C; Lamb DJ
    FASEB J; 2022 Nov; 36(11):e22567. PubMed ID: 36196997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL.
    Ungewiss C; Rizvi ZH; Roybal JD; Peng DH; Gold KA; Shin DH; Creighton CJ; Gibbons DL
    Sci Rep; 2016 Jan; 6():18652. PubMed ID: 26728244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer.
    Kim YH; Kwei KA; Girard L; Salari K; Kao J; Pacyna-Gengelbach M; Wang P; Hernandez-Boussard T; Gazdar AF; Petersen I; Minna JD; Pollack JR
    Oncogene; 2010 Mar; 29(10):1421-30. PubMed ID: 19966867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential roles of Crk and CrkL in fibroblast structure and motility.
    Park TJ; Curran T
    Oncogene; 2014 Oct; 33(43):5121-32. PubMed ID: 24166500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.